Efficacy of Intrathecal Isoniazid and Steroid Therapy in Refractory Tuberculous Meningitis-Reference-Cited by-同舟云学术

Efficacy of Intrathecal Isoniazid and Steroid Therapy in Refractory Tuberculous Meningitis

Published:2023 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ashizawa Nobuyuki¹,Kubo Ryotaro²,Tagawa Ryuta²,Ito Yuya²,Takeda Kazuaki²,Ide Shotaro³,Iwanaga Naoki²,Fujita Ayumi¹,Tashiro Masato¹,Takazono Takahiro⁴,Tanaka Takeshi¹,Nagaoka Atsushi⁵,Yoshimura Shunsuke⁵,Ujifuku Kenta⁶,Koga Tomohiro⁷,Ishii Koji⁸,Yamamoto Kazuko⁹,Furumoto Akitsugu³,Izumikawa Koichi¹,Yanagihara Katsunori¹⁰,Mukae Hiroshi²

Affiliation:

1. Infection Control and Education Center, Nagasaki University Hospital, Japan

2. Department of Respiratory Medicine, Nagasaki University Hospital, Japan

3. Infectious Diseases Experts Training Center, Nagasaki University Hospital, Japan

4. Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan

5. Department of Neurology and Strokology, Nagasaki University Hospital, Japan

6. Department of Neurosurgery, Nagasaki University Graduate School of Biomedical Sciences, Japan

7. Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan

8. Palliative Care Center, Nagasaki University Hospital, Japan

9. Division of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus Graduate School of Medicine, Japan

10. Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1917-23/_pdf

Reference7 articles.

1. 1. Wen L, Li M, Xu T, Yu X, Wang L, Li K. Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. J Neurol 266: 3009-3021, 2019.

2. 2. Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol 269: 3482-3494, 2022.

3. 3. Chen J, Feng X, Wang H, et al. Discriminating infectious meningitis versus neuropsychiatric involvement in patients with systemic lupus erythematosus: a single-center experience. Clin Rheumatol 34: 365-369, 2015.

4. 4. Deijns SJ, Broen JCA, Kruyt ND, et al. The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines. Autoimmun Rev 19: 102592, 2020.

5. 5. Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 63: e147-e195, 2016.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of intrathecal dexamethasone combined with isoniazid in the treatment of tuberculous meningitis: a meta-analysis;BMC Neurology;2024-06-10

2. Clinical research progress on intrathecal glucocorticoids in the treatment of infections: A review;Medicine;2024-05-17